E Fund Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Buy |
5,761
+365
| +7% | +$23.1K | 0.02% | 273 |
|
|
2025
Q1 | $286K | Buy |
+5,396
| New | +$286K | 0.01% | 321 |
|
|
2024
Q4 | – | Sell |
-4,149
| Closed | -$217K | – | 409 |
|
|
2024
Q3 | $217K | Buy |
+4,149
| New | +$217K | 0.01% | 312 |
|
|
2024
Q2 | – | Sell |
-10,333
| Closed | -$448K | – | 368 |
|
|
2024
Q1 | $448K | Buy |
10,333
+3,800
| +58% | +$165K | 0.03% | 175 |
|
|
2023
Q4 | $300K | Buy |
+6,533
| New | +$300K | 0.02% | 230 |
|
|
2023
Q3 | – | Sell |
-13,948
| Closed | -$230K | – | 316 |
|
|
2023
Q2 | $230K | Sell |
13,948
-536
| -4% | -$8.84K | 0.02% | 261 |
|
|
2023
Q1 | $258K | Sell |
14,484
-1,572
| -10% | -$28K | 0.02% | 256 |
|
|
2022
Q4 | $468K | Sell |
16,056
-1,979
| -11% | -$57.7K | 0.04% | 140 |
|
|
2022
Q3 | $442K | Buy |
+18,035
| New | +$442K | 0.04% | 156 |
|